PODD — INSULET CORP
—
Nasdaq ·
Health Care ·
Health Care Equipment & Supplies ·
CIK 1145197 ·
Last close
$148.14
Market Cap
$10.26B
52W High
$233.26
52W Low
$140.63
ADV30
1,670,002
Next earnings
2026-08-06
Quarterly Fundamentals
Revenues vs Net Income (last 4 Q)
Assets vs Liabilities (last 4 Q)
| Period | Revenues | GrossProfit | OpIncome | NetIncome | Assets | Cash | Liabilities |
|---|---|---|---|---|---|---|---|
| Mar 2026 | 761,700,000 | 529,100,000 | 122,200,000 | 91,100,000 | 2,987,200,000 | 480,400,000 | 1,684,600,000 |
| Dec 2025 | 783,800,000 | 568,600,000 | 146,300,000 | 101,600,000 | 3,190,400,000 | 716,100,000 | 1,675,100,000 |
| Sep 2025 | 706,300,000 | 510,100,000 | 117,700,000 | 87,600,000 | 3,029,300,000 | 757,500,000 | 1,645,000,000 |
| Jun 2025 | 649,100,000 | 452,200,000 | 121,100,000 | 22,500,000 | 3,469,200,000 | 1,121,500,000 | 2,006,900,000 |
Cashflow TTM (yfinance, fills SEC gap)
Operating CF
$619,200,000
Investing CF
$-234,700,000
Financing CF
$-1,192,800,000
CapEx
$-231,500,000
Dividends Paid
—
Buybacks
$-359,600,000
EPS Diluted TTM
$4.30
As of
2026-05-10
Balance + Analyst (yfinance extras)
Retained Earnings
$378,500,000
Inventory
$462,500,000
Receivables
$544,600,000
ST Investments
—
EBIT TTM
$469,200,000
Pretax Income TTM
$404,400,000
Interest Exp TTM
$64,800,000
Analysts
23
Yahoo Snapshot (yfinance, live)
Total Revenue
$2,900,800,000
EBITDA
$602,000,000
Free Cash Flow
$253,375,008
Enterprise Value
$10,794,468,352
Total Cash
$480,400,000
Total Debt
$1,014,000,000
Shares Out
69,264,674
Trailing EPS
$4.28
Book Value
$18.81
ROE
23.0%
ROA
9.7%
Div Yield
—
Annual Trend (SEC EDGAR, last 4y)
Revenues vs Net Income (last 4y)
| FY end | Revenues | OpIncome | NetIncome | Assets | Liabilities | Equity | OCF |
|---|---|---|---|---|---|---|---|
| Dec 2025 | 2,708,100,000 | 473,800,000 | 247,100,000 | 3,190,400,000 | 1,675,100,000 | — | 569,300,000 |
| Dec 2024 | 2,071,600,000 | 308,900,000 | 418,300,000 | 3,087,700,000 | 1,876,100,000 | — | 430,200,000 |
| Dec 2023 | 1,697,100,000 | 220,100,000 | 206,300,000 | 2,588,200,000 | 1,855,500,000 | — | 145,700,000 |
| Dec 2022 | 1,305,300,000 | 37,600,000 | 4,600,000 | 2,251,100,000 | 1,774,700,000 | — | 119,000,000 |
TTM Snapshot
Revenues TTM
$1,593,000,000
NetIncome TTM
$136,800,000
OpCashFlow TTM
$0
Assets (Latest)
$3,087,700,000
Forward EPS
$8.08
Max Pain — expiry 2026-06-18
max pain strike: $200.00 · spot: $147.01 · call oi: 1,440 · put oi: 2,643
Expected Move to 2026-06-18:
±$6.47
(4.40%) —
implied range
$140.54 –
$153.49
· ATM straddle on $145.00 strike
Peers — same industry
| Ticker | Name | Market Cap | Last | Daily % |
|---|---|---|---|---|
| BAX | BAXTER INTERNATIONAL INC | $10.75B | $20.81 | — |
| MASI | MASIMO CORP | $9.42B | $179.95 | — |
| GMED | GLOBUS MEDICAL INC | $8.76B | $77.32 | — |
| PEN | Penumbra Inc | $12.52B | $318.21 | — |
| ALGN | ALIGN TECHNOLOGY INC | $12.77B | $178.26 | — |
News headlines (Yahoo Finance, 1h cache)
If You’re Looking for the ‘Next Big Thing’ Before the OpenAI and Anthropic IPOs, Try This Barchart Stock Screener
2026-06-15 18:38 · Yahoo
2 S&P 500 Stocks to Target This Week and 1 That Underwhelm
2026-06-15 12:44 · Yahoo
Is Insulet Corporation (PODD) A Good Stock To Buy Now?
2026-06-11 20:26 · Yahoo
Assessing Insulet (PODD) Valuation After New Omnipod Clinical Data And System Updates
2026-06-11 11:08 · Yahoo
Insulet (PODD) Enhances Omnipod 5 System with New Target Glucose Option
2026-06-08 03:44 · Yahoo
Insulet Reveals New Data Supporting Breakthrough Omnipod® 6 and Fully Closed-Loop AID Systems Designed to Improve Outcomes, Reduce Effort, and Unlock Barriers to Care
2026-06-06 11:00 · Yahoo
Why Is Insulet (PODD) Down 8.7% Since Last Earnings Report?
2026-06-05 15:30 · Yahoo
Dexcom buys Nutrisense; Insulet rolls out patch pump update
2026-06-05 10:25 · Yahoo
Is Omnipod 5’s Algorithm and Libre 3 Plus Upgrade Altering The Investment Case For Insulet (PODD)?
2026-06-05 08:15 · Yahoo
3 Reasons We’re Fans of Insulet (PODD)
2026-06-04 16:45 · Yahoo
Recent Insider Activity
No insider activity indexed for this ticker.